SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ecoscience (ECSC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Harmon who wrote (4)8/5/1996 1:10:00 AM
From: WWS   of 145
 
Steve, I'm not sure that ECSC is really a take-over target. None of their technology is as potentially revolutionary as Calgene's, nor is it unique. For instance, ECSC licenses its Bio-save technology from U. of Washington, who also licenses similar technology to at least one other company. And, at present, much of ECSC's revenues come from the fruit sorting and grading equipment that they license from a European outfit (and again, apparently not on an exclusive basis). I'm still "bullish" on the company as a real "value" play, but not as yet as a potential takeover target. Maybe after they've proven the market for bio-blast and bio-save they'll be a lot more attractive as a potential takeover. Just my opinion, though, and you could well be correct; time will tell the answer.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News